April 26, 2010
No kidding. I mean it. Transparency is one of those buzz words that doesn't really mean much to people, because it means so many things to so many people. As a result, in some ways, the word has lost its … Continue reading →
February 23, 2010
Given the dismal track record of the U.S. Senate in the 111th Congress in producing important legislation to improve the lives of Americans, it appears that some of that body's members are looking for new things to do. In the … Continue reading →
February 17, 2010
The FDA has made a clear effort at promoting transparency and engaging consumers more directly with its Transparency Initiative and in putting out requests to get input from the public, such as the recent Part 15 meetings on social media. … Continue reading →
September 17, 2009
Back in July, in response to the formation of the FDA's Transparency Task Force, I wrote a posting called "When Transparency is Easy – Advisory Committee Transparency". The point made was that while it used to be quite easy to … Continue reading →
June 17, 2009
Today the Washington Post has an article – "FDA Commissioner Faces Formidable To Do List" that outlines the many challenges that Dr. Margaret Hamburg and Dr. Joshua Sharfstein face as they get settled into their new jobs. This includes the … Continue reading →